First Mid Bancshares, Inc. Announces Acquisition of Two Rivers Financial Group, Inc. GlobeNewswire October 30, 2025 MATTOON, Ill. and BURLINGTON, Iowa, Oct. 30, 2025 (GLOBE NEWSWIRE) — First Mid Bancshares, Inc. (NASDAQ: FMBH) (“First Mid”) and Two Rivers Financial Group, Inc. (OTCQX: TRVR) (“Two Rivers”) announced the execution of a definitive agreement dated October 29, […]

Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET GlobeNewswire October 30, 2025 HOLLISTON, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2025, before the market opens on November 6, 2025, and

Solid Biosciences to Participate at Upcoming Investor Conferences GlobeNewswire October 30, 2025 CHARLESTOWN, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences: 2025 Truist Securities BioPharma SymposiumDr.

Lisata Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update on Thursday, November 6, 2025 GlobeNewswire October 30, 2025 BASKING RIDGE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors

Diabetes Canada launches campaign to combat harmful myths and misinformation New national survey reveals widespread misinformation fueling blame, shame and judgment faced by millions of people living with diabetes in Canada GlobeNewswire October 30, 2025 Toronto, Oct. 30, 2025 (GLOBE NEWSWIRE) — This Diabetes Awareness Month, Diabetes Canada is launching a new campaign to confront

Kalaris to Present at Stifel 2025 Annual Healthcare Conference GlobeNewswire October 30, 2025 PALO ALTO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Kalaris Therapeutics, Inc. (Nasdaq: KLRS) (“Kalaris”), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today announced that management will present at the upcoming Stifel 2025

UroGen Pharma to Report Third Quarter 2025 Financial Results on Thursday, November 6th, 2025 Conference Call and Webcast Scheduled for Thursday, November 6th, 2025, at 10:00 AM ET GlobeNewswire October 30, 2025 PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions

Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025 GlobeNewswire October 30, 2025 BRISBANE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will report its

T-knife Therapeutics Announces Four Upcoming Data Presentations on PRAME-Targeted TK-6302 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting GlobeNewswire October 30, 2025 — Posters will review product characterization and manufacturing data on T-knife's lead program, TK-6302, a supercharged PRAME T cell receptor therapy that is advancing towards the clinic, with the filing of

Next-Generation of Optical Ethernet PHY Transceivers Deliver Precision Time Protocol and MACsec Encryption for Long-Reach Networking Microchip's new transceivers are offered at speeds up to 25 Gbps to process more data GlobeNewswire October 30, 2025 CHANDLER, Ariz., Oct. 30, 2025 (GLOBE NEWSWIRE) — The rise of smart factories, remote monitoring and connected infrastructure are increasing